Trials / Completed
CompletedNCT01657877
Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice
In Situ Study to Confirm the Anti-caries Potential of a 1.1365% w/w Sodium Monofluorophosphate (1500ppm F) Dentifrice
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
In situ study to compare treatment effect on enamel remineralization potential, measured by surface microhardness recovery (SMHR) and Enamel Fluoride Uptake (EFU). The study will explore the efficacy of an experimental sodium monofluorophosphate (SMFP) dentifrice containing calcium sodium phosphosilicate (CSP) in comparison to an experimental SMFP only dentifrice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium sodium phosphosilicate | CSP high percentage weight by weight |
| DRUG | Sodium monoflurophosphate | 500 to 1500 parts per million (ppm) of fluoride |
| DRUG | Placebo | No CSP and no fluoride |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-08-06
- Last updated
- 2014-10-01
- Results posted
- 2014-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01657877. Inclusion in this directory is not an endorsement.